文献速递心外重症与机械循环支持

体外膜氧合患者呼吸暂停试验与脑死亡判定的系统综述

The use of apnea test and brain death determination in patients on extracorporeal membrane oxygenation: A systematic review.
PubMed 文献 · J Thorac Cardiovasc Surg · 2020-03-21

该系统综述检索PubMed等6个数据库至2019年5月22日,纳入22项研究共177例成人ECMO患者,评估脑死亡判定方法。结果显示50%患者接受呼吸暂停试验,但22%试验因血流动力学不稳、缺氧、CO2上升不足或可靠性差而无法确认;仅12%患者仅凭确认性呼吸暂停试验即宣告脑死亡,支持在ECMO患者中使用辅助检查判定脑死亡。

要点

  • ECMO患者呼吸暂停试验失败率高,常见原因为血流动力学不稳、缺氧和CO2上升不足。
  • 多数患者需辅助检查确认脑死亡,仅12%仅凭呼吸暂停试验宣告脑死亡。
  • 呼吸暂停试验实施方式差异大,最常见为降低ECMO扫气流。

核心结论

  • ECMO患者进行呼吸暂停试验与高失败率和血流动力学并发症相关。
  • 研究强调呼吸暂停试验实践存在变异性,支持使用辅助检查判定ECMO患者脑死亡。

研究设计与样本

  • 系统综述检索PubMed和6个电子数据库,从建库至2019年5月22日。
  • 纳入报告成人(>18岁)ECMO期间脑死亡评估方法的研究,共22项研究177例患者。

主要发现

  • 19例(22%)呼吸暂停试验因血流动力学不稳、缺氧、CO2上升不足或可靠性差而无法确认。
  • 共进行157次辅助检查,包括脑电图(62%)、CT血管造影(22%)、经颅多普勒超声(6%)等。
  • 仅21例(全部患者的12%)仅凭确认性呼吸暂停试验宣告脑死亡而未使用辅助检查。

关键数值与推荐

  • 呼吸暂停试验实施方式:降低ECMO扫气流(14项研究,n=42,48%)、经呼吸机提供CO2(2项研究,n=6,7%)、经ECMO氧合器提供CO2(1项研究,n=1,1%)。
  • 2项研究(n=39,44%)未报告呼吸暂停试验细节。

临床怎么用

  • 对ECMO患者进行脑死亡判定时,应预期呼吸暂停试验可能失败并注意血流动力学并发症。
  • 支持在ECMO患者中使用辅助检查确认脑死亡,不应仅依赖呼吸暂停试验。

局限性

  • 纳入研究数量有限(22项,177例患者),部分研究未报告呼吸暂停试验细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To review practices of brain death (BD) determination in patients on extracorporeal membrane oxygenation (ECMO). METHODS: A systematic search was applied to PubMed and 6 electronic databases from inception to May 22, 2019. Studies reporting methods of BD assessment in adult patients (>18 years old) while on ECMO were included, after which data regarding BD assessment were extracted. RESULTS: Twenty-two studies (n = 177 patients) met the inclusion criteria. Eighty-eight patients (50%) in 19 studies underwent the apnea test (AT); most commonly through decreasing the ECMO sweep flow in 14 studies (n = 42, 48%), followed by providing CO2 through the ventilator in 2 studies (n = 6, 7%), and providing CO2 through the ECMO oxygenator in 1 study (n = 1, 1%). The details of the AT were not reported in 2 studies (n = 39, 44%). In 19 patients (22%), the AT was nonconfirmatory due to hemodynamic instability, hypoxia, insufficient CO2 rise, or unreliability of the AT. A total of 157 ancillary tests were performed, including electroencephalogram (62%), computed tomography angiography (22%), transcranial Doppler ultrasound (6%), cerebral blood flow nuclear study (5%), cerebral angiography (4%), and other (1%). Forty-seven patients (53% of patients with AT) with confirmatory AT still underwent additional ancillary for BD confirmation. Only 21 patients (12% of all patients) were declared brain-dead using confirmatory ATs alone without ancillary testing. CONCLUSIONS: Performing AT for patients with ECMO was associated with high failure rate and hemodynamic complications. Our study highlights the variability in practice in regard to the AT and supports the use of ancillary tests to determine BD in patients on ECMO.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Migdady I, Stephens RS, Price C, et al. The use of apnea test and brain death determination in patients on extracorporeal membrane oxygenation: A systematic review. J Thorac Cardiovasc Surg. 2020. PMID: 32312535. doi:10.1016/j.jtcvs.2020.03.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。